What is PocDoc?
PocDoc operates at the intersection of mobile technology and clinical diagnostics. The company has developed a sophisticated digital platform that enables users to perform quantitative blood tests via a simple fingerprick, with results processed and interpreted directly through a smartphone or tablet application. This end-to-end health assessment model provides immediate, actionable insights, allowing users to manage their health proactively.
Currently, the company's product portfolio is anchored by its proprietary Lipid Test. However, the firm maintains a robust development pipeline, with strategic plans to expand its diagnostic capabilities to include rapid testing for diabetes, kidney disease, liver disease, and specialized female health markers. By integrating in-house laboratory expertise with user-friendly digital interfaces, PocDoc is establishing a new standard for decentralized medical testing.
How much funding has PocDoc raised?
PocDoc has raised a total of $6.1M across 1 funding round:
Angel/Seed
$6.1M
Angel/Seed (2023): $6.1M with participation from MMC Ventures, Simplyhealth Group, and Forward Partners
Key Investors in PocDoc
MMC Ventures
A London-based venture capital firm specializing in early-stage investments and private equity, known for supporting high-growth technology companies.
Simplyhealth Group
A leading provider of everyday health cash plans and dental payment services with a long-standing commitment to healthcare innovation and charitable partnerships.
Forward Partners
A focused venture capital firm that employs a specialized investment strategy to provide targeted support and operational guidance to its portfolio companies.
What's next for PocDoc?
The infusion of capital from this major strategic investment will be primarily directed toward the expansion of the company's diagnostic test menu and the enhancement of its digital health ecosystem. As PocDoc transitions from its early-stage development phase into a period of rapid commercial scaling, the focus will shift toward regulatory approvals for new test kits and the integration of its platform into broader healthcare networks.
Looking ahead, the company is poised to capitalize on the growing demand for remote patient monitoring and preventative health solutions. By continuing to refine its proprietary quantitative blood tests, PocDoc aims to solidify its position as a leader in the digital health sector, ultimately reducing the burden on traditional healthcare systems while empowering patients with real-time, data-driven health management tools.
